News (Ukraine, World)
For the first time in the world placental stem cells, processed by ICT have restored the hopelessly damaged heart
The Ukrainian scientists succeeded to achieve an incredible success in the treatment of heart failure of critical degree after myocardial infarction. For the first time in the world cardiac surgeons of the National Institute of Cardiovascular Surgery n.a. MM Amosov of AMS of Ukraine...
ICT was presented at the scientific meeting of the International Federation of Placenta Associations
August 30 - September 2, 2017, Manchester (the United Kingdom of Great Britain and Northern Ireland) hosted the annual scientific meeting of the International Federation of Placenta Associations (IFPA).
The city of Manchester for the conduction of such a high level...
New application of umbilical cord blood
For the first time in the world, hematopoietic stem cells of the umbilical cord blood were used in 1988 to treat Fanconi anemia. Since then, umbilical cord blood is widely used as an alternative to bone marrow source for hematopoietic stem cells...
Released the next issue of the journal “Cell and organ transplantology”
Cell and Organ Transplantology, 2017, Vol. 5, No. 1
CONTENT
The effect of human adipose-derived multipotent mesenchymal stromal cells in the fibrin gel on the healing of full-thickness skin excision wounds in mice
Tykhvynskaya O. A, Rogulska O. Yu., Volkova N. A, Revenko...The number of scientific publications on stem cells has exceeded 300,000 articles worldwide
Stem cells are the hope of scientists to overcome many incurable diseases in the future! But now the transplantation of hematopoietic stem cells already cures leukemia, lymphoma, and some forms of cancer.
So, stem cells are one of the most popular research...
One more article of ukrainian scientists was accepted by the prestigious international scientific journal
In the modern scientific world the status of a scientist or a research team is determined by the level of scientific publications, i.e. by the impact factor of the journal, accepting their papers. Therefore, the publication of a scientific article in...
Mesenchymal stem cells are studied for the treatment of Alzheimer’s disease
In May 2017, in USA the company “Longeveron”, specializing on regenerative medicine drugs announced about the beginning of phase 1 of the clinical trial on the evaluation of the safety, tolerability and efficacy of mesenchymal stem cells in the treatment of Alzheimer’s disease.
Umbilical cord blood could ease symptoms of autism
A study observed the children over six and 12 months following the blood infusion.
Cells from umbilical cord blood have been tested as a method of treating autistic children and easing their symptoms, according to a recent study by researchers...










